Abstract:Elliot Dinetz, 1 Claudia Zeballos-Palacios, 2 Claudia A Martinez 3 1 Department of Integrative and Family Medicine, University of Miami Miller School of Medicine Miami, Miami, FL, USA; 2 Department of Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA; 3 Department of Medicine, Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL, USA Correspondence: Elliot Dinetz, Tel +786.490.5915, Email The aim of this manuscript is to provide a review of available options to enhance cardiovascular health and prevent cardiovascular disease (CVD) in the aging population using a systems-biology approach. These include the role of the gut microbiome, the early identification and removal of environmental toxins, and finally age related sex hormones and supplement replacement which all influence aging. Implementing such a comprehensive approach has the potential to facilitate earlier risk assessment, disease prevention, and even improve mortality. Further study in these areas will continue to advance our understanding and refine therapeutic interventions for a healthier cardiovascular aging process. Keywords: vascular aging, cardiovascular aging, inflammaging, systems biology medicine, microbiome, toxic metals, bioidentical hormone replacement According to the US Bureau of the Census, individuals aged 85 and older are now the fastest growing population. It is estimated that by 2030, 20% of the population will be over 65 years of age. The life expectancy over the recent years has been declining while this demographic shift has been accompanied by a significant increase in age-related chronic diseases, particularly cardiovascular disease (CVD). It is widely accepted that atherosclerosis, a primary driver of CVD, is primarily caused by inflammation at the endovascular level, yet most treatments fail to address their cause. 1 Aging itself is a major independent risk factor for CVD, which remains one of the leading causes of disability and death in the United States. 2 As shown in different studies, age-related arterial dysfunction was found in the absence of conventional cardiovascular risk factors, suggesting that age-related arterial dysfunction is a primary effect of advancing age. 3,4 This phenomenon persists despite best efforts to promote healthy lifestyle and pharmacological treatments. Additionally, it is worth noting that as much as 20% of individuals who develop coronary heart disease lack conventional risk factors. 5 This suggests there are still unaddressed factors missing from the current approach to patient management. Furthermore, another study showed that up to 70% of individuals who experienced myocardial infarctions were classified as low risk based on conventional 10-year coronary heart disease risk screening. 6 These findings are particularly concerning given the impact on morbidity and mortality in the United States, where the country ranks last out of 11 developed nations in terms of health care cost and avoidable mortality. 7 Recent evidence suggests that three finite physiological responses to numerous insults exist in the human body, attributing to the pathophysiology of CVD: oxidative stress, inflammation, and ultimately vascular dysfunction. 8,9 This process, often referred to as vascular aging or "Inflammaging", encompasses the complex interplay of molecular and cellular events like immune dysregulation associated with aging and the acceleration of age-related diseases. 10 Consequently, it is essential to consider certain overlooked and novel factors that contribute to aging as a process also contributing to the origin of traditional risk factors. For example, the gut microbiome-a complex ecosystem of organisms located throughout our body organs, including the gastrointestinal tract, serving as a transducer of environmental signals to the rest of the body-contributing either to promoting or reducing systemic inflammation and age-related cardiovascular disease risk. 11,12 Understanding such factors is needed to be able to address them. In this manuscript the evidence behind this system-biology approach will be reviewed to help identify targets improve cardiovascular health. Recent advancements in our understanding of aging have highlighted the crucial role of the gut microbiome, a complex ecosystem comprising bacteria and various other organisms, both commensal and pathogenic. Imbalances in this microbial composition have shown to influence overall health, including CVD. 13 As individuals age, there is a notable shift in the human microbiota. Two predominant bacterial phyla, Firmicutes and Bacteroidetes, play a crucial role in maintaining a healthy microbiome. 14,15 Disruptions -Abstract Truncated-

Gut microbial age modulates cardiovascular disease risk in metabolically unhealthy older people

Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk

Gut Microbial Features and Circulating Metabolomic Signatures of Frailty in Older Adults

Healthy and Unhealthy Aging and the Human Microbiome

Aged Gut Microbiome Induces Metabolic Impairment and Hallmarks of Vascular and Intestinal Aging in Young Mice

A gut aging clock using microbiome multi-view profiles is associated with health and frail risk

Association between Gut Microbiota and Biological Aging: A Two-Sample Mendelian Randomization Study

Age and aging process alter the gut microbes

Gut microbiome and aging: Physiological and mechanistic insights

Ageing, microbes and health

Murine Gut Microbiome Meta-analysis Reveals Alterations in Carbohydrate Metabolism in Response to Aging

Association of the Gut Microbiota With Cognitive Function in Midlife

Gut microbiota as the key controllers of “healthy” aging of elderly people

Age-related gut microbiota transplantation disrupts myocardial energy homeostasis and induces oxidative damage

Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study

Age‐dependent changes in the gut microbiota and serum metabolome correlate with renal function and human aging

Gut microbiome in healthy aging versus those associated with frailty

Gut microbes may influence cardiovascular health

Addressing the Missing Links in Cardiovascular Aging

Identification of gut microbiome signatures associated with longevity provides a promising modulation target for healthy aging

Identification of fecal microbiome signatures associated with familial longevity and candidate metabolites for healthy aging